AI agents that accelerate commercial wins, R&D breakthroughs, and IP advantage
Book a DemoSurface purchase-ready accounts, automate RFP responses, and link scientific buzz to product demand - driving pipeline growth and marketing ROI.
| # | URL | Fit | Size | Country |
|---|---|---|---|---|
| 1 | biocatalyst.ai | High | Medium | United States |
| 2 | genomexlabs.com | Medium | Large | Canada |
| 3 | neurovax.io | Low | Small | United Kingdom |
| 4 | oncoviewrx.com | High | Large | Germany |
| 5 | theragenics.co | Medium | Small | Japan |
| 6 | nexera.bio | Low | Medium | Israel |
| 7 | cellicon.ai | High | Small | South Korea |
| Company | Fit | Lead Score |
|---|---|---|
| 92 | ||
| 87 | ||
| 80 | ||
| 74 | ||
| 67 |
Score leads, automate RFPs, and track competitor pricing - boost win rates by 30%+
Track emerging technologies, analyze clinical trials, and identify white spaces faster
Track patent landscapes, run litigation, and protect your innovation pipeline
This analysis of 42 experimental studies demonstrates that CRISPR-Cas9 achieves 95% targeting accuracy and enables precise genetic modifications across multiple model organisms.
Connect publications to market trends and identify collaboration opportunities
From commercial wins to R&D breakthroughs to regulatory compliance - discover why leading biopharma providers choose Raycaster
Book a Demo